Mind Medicine (MindMed) Inc MNMD

Alternate Symbol(s): N.MMED | N.MMED.WA | N.MMED.WR | N.MMED.WS

Healthcare

Mind Medicine (MindMed) Inc. is a clinical-stage biopharmaceutical company, which is engaged in developing products to treat brain health disorders. It is developing a pipeline of product candidates, with and without acute perceptual effects, targeting neurotransmitter pathways. This specifically includes pharmaceutically optimized product candidates derived from the psychedelic and empathogen drug classes, including MM-120 and MM-402, the Company's product candidates. MM120, is a proprietary, pharmaceutically optimized form of lysergide D-tartrate that it is developing for the treatment of generalized anxiety disorder (GAD). MM-120 is also being studied in a subperceptual repeat administration dosing regimen for the treatment of attention deficit hyperactivity disorder (ADHD). MM-402, also referred to as R(-)-MDMA, is the Company's form of the R-enantiomer of 3,4-methylenedioxymethampheta (MDMA), which the Company is developing for the treatment of autism spectrum disorder (ASD).

NDAQ:MNMD - Post by User

Mind Medicine (MindMed) Inc > Canaccord’s rule of thumb

<< Previous

Bullboard Posts

Next >>

Comment by MiningGospelon Apr 08, 2021 9:37pm

442 Views

Post# 32964451

RE:Canaccord’s rule of thumb

This is so inaccurate. Cannacord hedges and will use shares and warrants from finance deals to cover their naked shorts as they slowly kill the SP

maysteeler23 wrote: Ive been following Canaccord for 20 years. They like to 3x -5x PP prices.

recent PP are $3.20 and $4.40

3x $3.20 =$9.60

3x $4.40 = $13.20

Means we are going there soon. Their business model is to guarantee their clients 3x quick. They are the master of the universe for Canadian penny stocks.

5 x $3.20 =$16

5 x $4.40.= $22

Once Canaccord set this rocket ship free we will be +$10

With Wallstreetbets we can get #$30 in one day